INTRODUCTION: It has been clearly established that thrombolysis using recombinant tissue plasminogen activator is strongly beneficial for acute stroke patients. The sensitivity of brain tissue to ischemia causes this time dependence on the effectiveness of recombinant tissue plasminogen activator. Early recognition of stroke and activation of a stroke alert/code are imperative to treat acute stroke patients effectively and to realize positive outcomes. CASE PRESENTATION: A 68-year-old man with right-sided weakness arrived at our emergency room and was thrombolysed in 6 minutes from time of arrival, after ruling out all contraindications. CONCLUSION: The case and our rapid thrombolysis protocol that helped in achieving the 6-minute door-to-needle time are described. A structured protocol is recommended to reduce door-to-needle times for thrombolysis in acute ischemic stroke.
INTRODUCTION: It has been clearly established that thrombolysis using recombinant tissue plasminogen activator is strongly beneficial for acute stroke patients. The sensitivity of brain tissue to ischemia causes this time dependence on the effectiveness of recombinant tissue plasminogen activator. Early recognition of stroke and activation of a stroke alert/code are imperative to treat acute stroke patients effectively and to realize positive outcomes. CASE PRESENTATION: A 68-year-old man with right-sided weakness arrived at our emergency room and was thrombolysed in 6 minutes from time of arrival, after ruling out all contraindications. CONCLUSION: The case and our rapid thrombolysis protocol that helped in achieving the 6-minute door-to-needle time are described. A structured protocol is recommended to reduce door-to-needle times for thrombolysis in acute ischemic stroke.
Authors: Kennedy R Lees; Erich Bluhmki; Rüdiger von Kummer; Thomas G Brott; Danilo Toni; James C Grotta; Gregory W Albers; Markku Kaste; John R Marler; Scott A Hamilton; Barbara C Tilley; Stephen M Davis; Geoffrey A Donnan; Werner Hacke; Kathryn Allen; Jochen Mau; Dieter Meier; Gregory del Zoppo; D A De Silva; K S Butcher; M W Parsons; P A Barber; C Levi; C Bladin; G Byrnes Journal: Lancet Date: 2010-05-15 Impact factor: 79.321
Authors: Gregg C Fonarow; Eric E Smith; Jeffrey L Saver; Mathew J Reeves; Adrian F Hernandez; Eric D Peterson; Ralph L Sacco; Lee H Schwamm Journal: Stroke Date: 2011-09-01 Impact factor: 7.914
Authors: Gregg C Fonarow; Eric E Smith; Jeffrey L Saver; Mathew J Reeves; Deepak L Bhatt; Maria V Grau-Sepulveda; DaiWai M Olson; Adrian F Hernandez; Eric D Peterson; Lee H Schwamm Journal: Circulation Date: 2011-02-10 Impact factor: 29.690
Authors: J R Marler; B C Tilley; M Lu; T G Brott; P C Lyden; J C Grotta; J P Broderick; S R Levine; M P Frankel; S H Horowitz; E C Haley; C A Lewandowski; T P Kwiatkowski Journal: Neurology Date: 2000-12-12 Impact factor: 9.910
Authors: Jane H Brice; Kelly R Evenson; Julie C Lellis; Wayne D Rosamond; Semra A Aytur; Jennifer B Christian; Dexter L Morris Journal: Prehosp Emerg Care Date: 2008 Jul-Sep Impact factor: 3.077
Authors: Edward C Jauch; Jeffrey L Saver; Harold P Adams; Askiel Bruno; J J Buddy Connors; Bart M Demaerschalk; Pooja Khatri; Paul W McMullan; Adnan I Qureshi; Kenneth Rosenfield; Phillip A Scott; Debbie R Summers; David Z Wang; Max Wintermark; Howard Yonas Journal: Stroke Date: 2013-01-31 Impact factor: 7.914
Authors: P M Dalal; S Malik; M Bhattacharjee; N D Trivedi; J Vairale; P Bhat; S Deshmukh; K Khandelwal; V D Mathur Journal: Neuroepidemiology Date: 2008-10-20 Impact factor: 3.282